These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10399151)

  • 1. Reconstitution of yeast farnesyltransferase from individually purified subunits.
    Urano J; Tamanoi F
    Methods Mol Biol; 1999; 116():145-59. PubMed ID: 10399151
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of yeast type-II geranylgeranyltransferase.
    Jiang Y; Rossi G; Ferro-Novick S
    Methods Enzymol; 1995; 257():21-9. PubMed ID: 8583924
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified yeast protein farnesyltransferase is structurally and functionally similar to its mammalian counterpart.
    Gomez R; Goodman LE; Tripathy SK; O'Rourke E; Manne V; Tamanoi F
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):25-31. PubMed ID: 8424764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assays for farnesyltransferase inhibitors with Saccharomyces cerevisiae.
    Mitsuzawa H; Tamanoi F
    Methods Enzymol; 1995; 250():43-51. PubMed ID: 7651169
    [No Abstract]   [Full Text] [Related]  

  • 6. Interplay between the cis-prenyltransferases and polyprenol reductase in the yeast Saccharomyces cerevisiae.
    Szkopinska A; Swiezewska E; Rytka J
    Biochimie; 2006; 88(3-4):271-6. PubMed ID: 16213651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note about computing all local alignments.
    Miller W; Boguski M
    Comput Appl Biosci; 1994 Jul; 10(4):455-6. PubMed ID: 7804880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous fluorescence assay for protein prenyltransferases.
    Cassidy PB; Dolence JM; Poulter CD
    Methods Enzymol; 1995; 250():30-43. PubMed ID: 7651159
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of yeast for identification of farnesyltransferase inhibitors and for generation of mutant farnesyltransferases.
    Tamanoi F; Mitsuzawa H
    Methods Enzymol; 1995; 255():82-91. PubMed ID: 8524140
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the activity of farnesyltransferase by capillary electrophoresis with laser-induced fluorescence detection.
    Berezovski M; Li WP; Poulter CD; Krylov SN
    Electrophoresis; 2002 Sep; 23(19):3398-403. PubMed ID: 12373769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient extraction of thioreodoxin from Saccharomyces cerevisiae by ethanol.
    Inoue Y; Nomura W; Takeuchi Y; Ohdate T; Tamasu S; Kitaoka A; Kiyokawa Y; Masutani H; Murata K; Wakai Y; Izawa S; Yodoi J
    Appl Environ Microbiol; 2007 Mar; 73(5):1672-5. PubMed ID: 17209065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique sequence repeats in the alpha-subunit of protein farnesyltransferases.
    Feng XH; Kung SD
    Trends Biochem Sci; 1993 Nov; 18(11):426-7. PubMed ID: 8291087
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein prenyltransferases.
    Casey PJ; Seabra MC
    J Biol Chem; 1996 Mar; 271(10):5289-92. PubMed ID: 8621375
    [No Abstract]   [Full Text] [Related]  

  • 14. Farnesyltransferase inhibitors.
    Adjei AA
    Cancer Chemother Biol Response Modif; 2001; 19():149-64. PubMed ID: 11686012
    [No Abstract]   [Full Text] [Related]  

  • 15. The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae.
    Szkopińska A; Swiezewska E; Karst F
    Biochem Biophys Res Commun; 2000 Jan; 267(1):473-7. PubMed ID: 10623644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyltransferase inhibitors.
    Adjei AA
    Cancer Chemother Biol Response Modif; 2002; 20():151-67. PubMed ID: 12703204
    [No Abstract]   [Full Text] [Related]  

  • 17. Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo.
    Wiesner J; Kettler K; Sakowski J; Ortmann R; Katzin AM; Kimura EA; Silber K; Klebe G; Jomaa H; Schlitzer M
    Angew Chem Int Ed Engl; 2004 Jan; 43(2):251-4. PubMed ID: 14695623
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of farnesyltransferase: 5-arylacryloylaminobenzophenones show antimalarial activity.
    Wiesner J; Ortmann R; Mitsch A; Wissner P; Sattler I; Jomaa H; Schlitzer M
    Pharmazie; 2003 Apr; 58(4):289-90. PubMed ID: 12749417
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by arylthienylacryloylaminobenzophenones.
    Mitsch A; Altenkämper M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2005 Jan; 338(1):9-17. PubMed ID: 15674808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
    Bell IM
    J Med Chem; 2004 Apr; 47(8):1869-78. PubMed ID: 15055985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.